» Articles » PMID: 28698957

The ZJU Index is a Powerful Index for Identifying NAFLD in the General Chinese Population

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2017 Jul 13
PMID 28698957
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The ZJU index is a novel model for detecting non-alcoholic fatty liver disease (NAFLD) that it is calculated based on combination of the body mass index, fasting plasma glucose, triglycerides, and the serum alanine aminotransferase-to-aspartate transaminase ratio. We aimed to evaluate the diagnostic accuracy of the ZJU index in detecting NAFLD in the Chinese population.

Methods: This was a cross-sectional study. Anthropometric measurements, laboratory data, and ultrasonography features were collected through a standard protocol. The ZJU index, fatty liver index, hepatic steatosis index, lipid accumulation product, and visceral adiposity index were calculated. Then the predictive values of the five indices were compared according to the area under receiver-operating characteristic curve (AUROC) values.

Results: A total of 19,804 participants were recruited, of whom 7324 participants were diagnosed with NFALD and 12,480 subjects were regarded as controls. The AUROC value for NAFLD identification by the ZJU index was 0.925 (95% confidence interval [CI]: 0.919-0.931), which was significantly higher than the values for the other four models (P < 0.001). Furthermore, from age 31 years to >60 years, the AUROC for the ZJU increased from 87.1 to 95.4%, values which were also greater than those for the other four indices. Analysis by sex also showed that the performance of the ZJU index in males and females was better than that of the other four indices.

Conclusions: The ZJU index is an accurate and easy to employ tool for identifying NAFLD in the general Chinese population.

Citing Articles

Correlation between ZJU index and hepatic steatosis and liver fibrosis in American adults with NAFLD.

Luo S, Weng X, Xu J, Lin H Front Med (Lausanne). 2024; 11:1443811.

PMID: 39211343 PMC: 11357965. DOI: 10.3389/fmed.2024.1443811.


Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.

Zheng K, Yin Y, Guo H, Ma L, Liu R, Zhao T Front Endocrinol (Lausanne). 2024; 15:1340644.

PMID: 38405152 PMC: 10884868. DOI: 10.3389/fendo.2024.1340644.


ZJU Index as a Predictive Tool for Diabetes Incidence: Insights from a Population-Based Cohort Study.

Wu C, Loh Y, Huang H, Xu C Diabetes Metab Syndr Obes. 2024; 17:715-724.

PMID: 38371391 PMC: 10873143. DOI: 10.2147/DMSO.S446042.


Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease.

Zou H, Ma X, Zhang F, Xie Y Lipids Health Dis. 2023; 22(1):145.

PMID: 37674196 PMC: 10481547. DOI: 10.1186/s12944-023-01902-3.


Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies.

Reinshagen M, Kabisch S, Pfeiffer A, Spranger J J Clin Transl Hepatol. 2023; 11(5):1212-1227.

PMID: 37577225 PMC: 10412706. DOI: 10.14218/JCTH.2022.00019.